查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1978148

全球髂動脈支架市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Iliac Stent Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 139 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

髂動脈支架市場預計將從 2025 年的 10.1 億美元成長到 2034 年的 16.4 億美元，2026 年至 2034 年的複合年成長率為 5.51%。

由於周邊動脈疾病(PAD) 的盛行率不斷上升以及生活型態相關血管疾病病例的增加，全球髂動脈支架市場正經歷穩定成長。尤其是在已開發國家，人口老化顯著推動了對微創血管治療的需求。自動擴張型支架和藥物釋放型支架的技術進步提高了手術成功率並降低了併發症，進一步加速了市場應用。

關鍵成長要素包括血管內手術的增加、人們對早期診斷動脈阻塞重要性的認知不斷提高，以及新興國家醫療基礎設施的擴張。住院時間和復健時間的縮短促使醫生擴大選擇支架置入術而非開放性手術。已開發國家有利的健保報銷政策也促進了市場擴張。

展望未來，生物可吸收支架的持續創新和先進影像引導手術技術的進步預計將對市場產生積極影響。增加對心血管檢查的投資以及將人工智慧融入血管診斷，有望進一步提高手術的精確度。亞太和拉丁美洲等新興市場由於能夠更便捷地取得先進醫療設備，預計將帶來盈利的市場機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球髂動脈支架市場：依類型分類

  • 市場分析、洞察與預測
  • 自動擴張型支架
  • 球囊擴張型支架
  • 覆膜支架

第5章：全球髂動脈支架市場：依動脈病變類型分類

  • 市場分析、洞察與預測
  • 髂總動脈病變
  • 嚴重鈣化病灶
  • 完全閉塞性病變

第6章 全球髂動脈支架市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 其他

第7章 全球髂動脈支架市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott Laboratories
    • Alvimedica
    • Becton
    • Dickinson And Company
    • Biotronik
    • Boston Scientific Corporation
    • B. Braun SE
    • Cook
    • Getinge AB
    • IVascular
    • Medtronic Plc
簡介目錄
Product Code: VMR112113948

The Iliac Stent Market size is expected to reach USD 1.64 Billion in 2034 from USD 1.01 Billion (2025) growing at a CAGR of 5.51% during 2026-2034.

The Global Iliac Stent Market is witnessing steady growth due to the rising prevalence of peripheral artery disease (PAD) and increasing cases of lifestyle-related vascular disorders. Aging populations, especially in developed nations, are contributing significantly to the demand for minimally invasive vascular interventions. Technological advancements in self-expanding and drug-eluting stents have improved procedural success rates and reduced complications, further accelerating market adoption.

Key growth drivers include the increasing number of endovascular procedures, growing awareness about early diagnosis of arterial blockages, and expanding healthcare infrastructure in emerging economies. Physicians are increasingly preferring stenting procedures over open surgeries due to shorter hospital stays and faster recovery times. Favorable reimbursement policies in developed countries also support market expansion.

Looking ahead, the market is expected to benefit from ongoing innovation in bioresorbable stents and advanced imaging-guided procedures. Rising investments in cardiovascular research and the integration of AI in vascular diagnostics may further enhance procedural accuracy. Emerging markets in Asia-Pacific and Latin America are projected to offer lucrative opportunities due to improving access to advanced medical devices.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Self-Expandable Stents
  • Balloon-Expandable Stents
  • Covered Stents

By Artery Lesions

  • Common Iliac Artery Lesions
  • Severe Calcified Lesions
  • Complete Obstructive Lesions

By End-Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Other

COMPANIES PROFILED

  • Abbott Laboratories, Alvimedica, Becton, Dickinson and Company, Biotronik, Boston Scientific Corporation, B Braun SE, Cook, Getinge AB, iVascular, Medtronic Plc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ILIAC STENT MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Self-Expandable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Balloon-Expandable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Covered Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ILIAC STENT MARKET: BY ARTERY LESIONS 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Artery Lesions
  • 5.2. Common Iliac Artery Lesions Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Severe Calcified Lesions Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Complete Obstructive Lesions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ILIAC STENT MARKET: BY END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-use
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ILIAC STENT MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Artery Lesions
    • 7.2.3 By End-use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Artery Lesions
    • 7.3.3 By End-use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Artery Lesions
    • 7.4.3 By End-use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Artery Lesions
    • 7.5.3 By End-use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Artery Lesions
    • 7.6.3 By End-use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ILIAC STENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Abbott Laboratories
    • 9.2.2 Alvimedica
    • 9.2.3 Becton
    • 9.2.4 Dickinson And Company
    • 9.2.5 Biotronik
    • 9.2.6 Boston Scientific Corporation
    • 9.2.7 B. Braun SE
    • 9.2.8 Cook
    • 9.2.9 Getinge AB
    • 9.2.10 IVascular
    • 9.2.11 Medtronic Plc